Topoisomerase II is nonfunctional in polyamine-depleted cells.
The polyamines-putrescine, spermidine, and spermine-are essential for normal cell proliferation. Polyamine depletion affects DNA structure and synthesis. Topoisomerase II (topo II) is also necessary for normal cell proliferation, and it has been shown in vitro that polyamines may affect topo II activity. In order to investigate the effect of polyamine depletion on topo II activity, we treated Chinese hamster ovary cells with either alpha-difluoromethylornithine (DFMO) or 4-amidinoindan-1-one-2'-amidinohydrazone (CGP 48664), which are polyamine biosynthesis inhibitors. Treatment with the topo II inhibitor etoposide results in DNA strand breaks only if there is active topo II in the cells. By quantitating DNA strand breaks after etoposide treatment using single cell gel electrophoresis, we were able to estimate intracellular topo II activity. We also quantitated topo II activity in crude nuclear extracts from control and polyamine biosynthesis inhibitor-treated cells. Using single cell gel electrophoresis, we noted a clear decrease in the function of topo II in polyamine biosynthesis inhibitor-treated cells, as compared with untreated control cells. However, the topo II activity in crude nuclear extracts did not differ significantly in control versus polyamine biosynthesis inhibitor-treated cells. Taken together, these results indicate that although the function of topo II in polyamine-depleted cells was impaired, topo II remained functional in an in vitro assay. Using the single cell gel electrophoresis assay, we also found that spermine depletion itself caused DNA strand breaks.
Alm
K
K
Department of Animal Physiology, Lund University, Lund, Sweden. kersti.alm@zoofys.lu.se
Berntsson
P
P
Oredsson
S M
SM
D012437:Adenosylmethionine Decarboxylase / Q000037:antagonists & inhibitors; D000578:Amidines / Q000494:pharmacology; D000818:Animals; D016466:CHO Cells; D002453:Cell Cycle / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D006224:Cricetinae; D004249:DNA Damage; D004250:DNA Topoisomerases, Type II / Q000378:metabolism*; D000518:Eflornithine / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005047:Etoposide / Q000494:pharmacology; D005434:Flow Cytometry; D007189:Indans / Q000494:pharmacology; D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines / Q000378:metabolism*; D013096:Spermine / Q000378:metabolism; D059005:Topoisomerase II Inhibitors
D000578:Amidines; D004791:Enzyme Inhibitors; D007189:Indans; D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines; D059005:Topoisomerase II Inhibitors; C082408:4-amidinoindan-1-one 2'-amidinohydrazone; D013096:Spermine; D005047:Etoposide; D012437:Adenosylmethionine Decarboxylase; D004250:DNA Topoisomerases, Type II; D000518:Eflornithine